Proposed Regulation of Tobacco Products by the U.S. Food and Drug Administration

Bills S. 625 / H.R. 1108
On February 15, 2007, U.S. Senator Edward Kennedy (D-MA) and John Cornyn (R-TX) and U.S. Representative Henry Waxman (D-CA) and Tom Davis (R-VA) introduced identical bipartisan bills to grant the U.S. Food and Drug Administration (FDA) the authority to regulate the tobacco industry. The intent of this legislation, known as the Family Smoking Prevention and Tobacco Control Act (S. 625/H.R. 1108) is to give the FDA the necessary tools and resources to regulate the manufacturing, marketing, labeling, distribution and sale of tobacco products.

Many national public health organizations support this legislation enthusiastically. Others have raised fundamental objections to the bill, with some critics suggesting the bill may actually be harmful to public health. To help members of the tobacco community formulate their own views, the Tobacco Control Network commissioned the Tobacco Control Legal Consortium to prepare publications containing a balanced explanation and summary of this complex 156-page bill. Our first publication is a series of eight Fact Sheets, which summarize by topic key elements of the pending legislation.

• Fact Sheet 1: An Overview
   
• Fact Sheet 2: Tobacco Product Standards
   
• Fact Sheet 3: Tobacco Product Marketing Restrictions
   
• Fact Sheet 4: Tobacco Product Labeling and Advertising Warnings
   
• Fact Sheet 5: Tar, Nicotine and Other Smoke Constituent Disclosures
   
• Fact Sheet 6: Litigation
   
• Fact Sheet 7: Preemption
   
• Fact Sheet 8: Preventing Illicit Trade in Tobacco Products
  

top

Back to Table of Contents